Results
Amneal Pharma Q3 Beat Fuels 67% AI Pick Gain
AI-selected Amneal Pharmaceuticals (NASDAQ: AMRX) rose 66.74% since June 1, 2026, after strong Q3 results.
Q3 adjusted EPS $0.30 beat consensus by 30.4%, revenue $796 million rose 10% YoY and 5% above
